Hydromorphone vs Fentanyl in Children Undergoing Tonsillectomy Surgery

Sponsor
Washington University School of Medicine (Other)
Overall Status
Recruiting
CT.gov ID
NCT04230681
Collaborator
(none)
300
1
2
35.2
8.5

Study Details

Study Description

Brief Summary

A RCT to compare hydromorphone versus fentanyl for pain control following tonsillectomy or adenotonsillectomy surgery.

Condition or Disease Intervention/Treatment Phase
Early Phase 1

Detailed Description

This is a randomized clinical trial with masked assessment, comparing recovery indices for patients receiving intermediate acting versus short acting opioid analgesia using hydromorphone or fentanyl as intraoperative analgesics. An otherwise standardized anesthetic and analgesic regimen will be utilized, consistent with routine care at SLCH. Patients will be randomized 1:1 in block sizes of 5 per group. Patients will be randomized to receive either hydromorphone or fentanyl throughout the perioperative period by opening a sealed protocol envelope.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
300 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Care Provider, Investigator)
Primary Purpose:
Treatment
Official Title:
A Randomized Controlled Trial to Compare Hydromorphone vs Fentanyl in Children Undergoing Tonsillectomy Surgery
Actual Study Start Date :
Feb 26, 2020
Anticipated Primary Completion Date :
Jan 31, 2023
Anticipated Study Completion Date :
Jan 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Fentanyl

Drug: Fentanyl
Fentanyl

Active Comparator: Hydromorphone

Drug: Hydromorphone
Patients will be randomized to one of two opioids for the treatment of post-operative pain.

Outcome Measures

Primary Outcome Measures

  1. Amount of rescue opioid medications administered - hydromorphone group [up to 48 hours post surgery]

    Postoperative opioid medication expressed in morphine equivalents

  2. Amount of rescue opioid medications administered - fentanyl group [up to 48 hours post surgery]

    Postoperative opioid medication expressed in morphine equivalents

  3. Evaluation of participant's pain - hydromorphone group [up to 48 hours post surgery]

    Revised Face, Legs, Activity, Cry, Consolability (rFLACC) Scale Each of the five categories (F) Face; (L) Legs; (A) Activity; (C) Cry; (C) Consolability is scored from 0-2, which results in a total score between zero and ten. 0=no pain/relaxed, 10=distressed/in pain

  4. Evaluation of participant's pain - fentanyl group [up to 48 hours post surgery]

    Revised Face, Legs, Activity, Cry, Consolability (rFLACC) Scale Each of the five categories (F) Face; (L) Legs; (A) Activity; (C) Cry; (C) Consolability is scored from 0-2, which results in a total score between zero and ten. 0=no pain/relaxed, 10=distressed/in pain

Secondary Outcome Measures

  1. Preoperative Amsterdam Preoperative Anxiety Scale - hydromorphone group [up to 12 hours prior to surgery]

    Caregiver of the participant is asked questions regarding the child's anxiety level prior to surgery. The questions asked: 1) I am worried about the anesthetic, 2) The anesthetic is on my mind continually, 3) I would like to know as much as possible about the anesthetic, 4) I am worried about the procedure, 5) The procedure is on my mind continually, 6) I would like to know as much as possible about the procedure The measure of agreement with these statements should be graded on a 5-point Likert scale from 1 "not at all" to 5 "extremely." A score of ≥11 identify anxious patients in clinical practice.

  2. Preoperative Amsterdam Preoperative Anxiety Scale - fentanyl group [up to 12 hours prior to surgery]

    Caregiver of the participant is asked questions regarding the child's anxiety level prior to surgery. The questions asked: 1) I am worried about the anesthetic, 2) The anesthetic is on my mind continually, 3) I would like to know as much as possible about the anesthetic, 4) I am worried about the procedure, 5) The procedure is on my mind continually, 6) I would like to know as much as possible about the procedure The measure of agreement with these statements should be graded on a 5-point Likert scale from 1 "not at all" to 5 "extremely." A score of ≥11 identify anxious patients in clinical practice.

  3. Yale Preoperative Anxiety Scale - hydromorphone group [up to 12 hours prior to surgery]

    Assessing child anxiety during the induction of anesthesia. It contains 22 items in 5 categories: activity, emotional expressivity, state of arousal, vocalization, and use of parents. Each category receives a score on a scale of 0 to 4 (6 for vocalization) according to the behavior of the patient, with 0 = no anxiety and 4 (or 6 for vocalization) = high anxiety.

  4. Yale Preoperative Anxiety Scale - fentanyl group [up to 12 hours prior to surgery]

    Assessing child anxiety during the induction of anesthesia. It contains 22 items in 5 categories: activity, emotional expressivity, state of arousal, vocalization, and use of parents. Each category receives a score on a scale of 0 to 4 (6 for vocalization) according to the behavior of the patient, with 0 = no anxiety and 4 (or 6 for vocalization) = high anxiety.

  5. ASA physical status classification score from preoperative assessment - hydromorphone group [up to 12 hours prior to surgery]

    ASA I A normal healthy patient ASA II A patient with mild systemic disease ASA III A patient with severe systemic disease ASA IV A patient with severe systemic disease that is a constant threat to life ASA V A moribund patient who is not expected to survive without the operation ASA VI A declared brain-dead patient whose organs are being removed for donor purposes

  6. ASA physical status classification score from preoperative assessment - fentanyl group [up to 12 hours prior to surgery]

    ASA I A normal healthy patient ASA II A patient with mild systemic disease ASA III A patient with severe systemic disease ASA IV A patient with severe systemic disease that is a constant threat to life ASA V A moribund patient who is not expected to survive without the operation ASA VI A declared brain-dead patient whose organs are being removed for donor purposes

  7. Optional opioid plasma concentrations - hydromorphone group [up to 48 hours after surgery]

    Blood collection at three time points using mass spectroscopy (This is optional for participants)

  8. Optional opioid plasma concentrations - fentanyl group [up to 48 hours after surgery]

    Blood collection at three time points using mass spectroscopy (This is optional for participants)

  9. Adverse events - hydromorphone group [up to 48 hours after surgery]

    Nausea/vomiting, witnessed apneic events, desaturation events, respiratory depression, re-intubation, decreased oxygen saturation

  10. Adverse events - fentanyl group [up to 48 hours after surgery]

    Nausea/vomiting, witnessed apneic events, desaturation events, respiratory depression, re-intubation, decreased oxygen saturation

  11. NIH PROMIS - hydromorphone group [up to 48 hours after surgery]

    Patient satisfaction, behavior and pain scores over past 7 days. Scale of 1 - 6, with 1=had no pain and 6=almost always

  12. NIH PROMIS - fentanyl group [up to 48 hours after surgery]

    Patient satisfaction, behavior and pain scores over past 7 days. Scale of 1 - 6, with 1=had no pain and 6=almost always

  13. NIH PROMIS - hydromorphone group [up to 48 hours after surgery]

    Patient caregiver satisfaction, behavior and pain scores over past 7 days. Scale of 1 - 6, with 1=had no pain and 6=almost always

  14. NIH PROMIS - fentanyl group [up to 48 hours after surgery]

    Patient caregiver satisfaction, behavior and pain scores over past 7 days. Scale of 1 - 6, with 1=had no pain and 6=almost always

  15. Child Hospital Survey (CAHPS) - hydromorphone group [up to 48 hours after surgery]

    Patient caregiver satisfaction. Scale of 1 - 4 with 1=never and 6=always

  16. Child Hospital Survey (CAHPS) - fentanyl group [up to 48 hours after surgery]

    Patient caregiver satisfaction. Scale of 1 - 4 with 1=never and 6=always

Eligibility Criteria

Criteria

Ages Eligible for Study:
2 Years to 15 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Children ages 2 to 15 years old

  2. Presenting for tonsillectomy or adenotonsillectomy surgery

  3. American Society of Anesthesiologists Physical Status (ASAPS) Classification 1, 2 or 3

  4. Provide Informed Consent / Assent (as appropriate)

Exclusion Criteria:
  1. Additional Concurrent surgeries, exclusive of myringotomy tubes, minor oral/nasal procedures (e.g. frenulectomy), and endoscopic procedures

  2. Revision tonsillectomy or revision adenotonsillectomy surgery

  3. Known pregnancy

  4. Any condition which would make the participant, in the opinion of the investigator or the attending anesthesiologist caring for the patient, unsuitable for the study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Washington University School of Medicine/Barnes-Jewish Hospital Saint Louis Missouri United States 63110

Sponsors and Collaborators

  • Washington University School of Medicine

Investigators

  • Principal Investigator: Michael Montana, MD PhD, Washington University School of Medicine

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Washington University School of Medicine
ClinicalTrials.gov Identifier:
NCT04230681
Other Study ID Numbers:
  • 201912042
First Posted:
Jan 18, 2020
Last Update Posted:
Mar 3, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
Yes
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 3, 2022